Illumina

Senior Territory Account Manager

Western Australia, Australia

Auto‑apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Life Sciences, HealthcareIndustries

Requirements

Candidates should possess a proven track record in Life Science or Medical devices, demonstrating impressive sales numbers and a strong understanding of sequencing technologies across clinical and research applications.

Responsibilities

The Senior Territory Account Manager will drive growth in volume, revenue, and share within new customers, co-create individual plans with regional and marketing leadership, execute account marketing plans, and actively seek and qualify new customers and sales opportunities through dialogue and solution development. They will articulate Illumina's value proposition, deliver sales presentations, negotiate terms and contracts, build customer relationships, and achieve key performance indicators and sales targets while supporting account transitions and contributing to company’s direct marketing capabilities.

Skills

Customer Outreach

Account Management

Sales Strategy

Relationship Building

Negotiation

CRM

Presentation Skills

Solution Selling

Market Analysis

Team Collaboration

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

Key Metrics

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free